Curcumin: A Review of its Potential Role in Epigenetic Mechanism http://www.doi.org/10.26538/tjnpr/v1i4.2
Main Article Content
Abstract
Curcumin, a golden-yellow powder extracted from the rhizome of the plant Curcuma longa L.(Family: Zingiberaceae) has been used as a therapeutic agent since ancient times. Curcumin is a diferuloylmethane type of compound having two ferulic acid moieties bound together through a methylene group stabilized by a hydrogen-bonded keto-enol tautomeric form. This tautomeric form is stable in acidic medium but unstable in neutral and basic pH solutions, where it is degraded to ferulic acid and feruloylmethane units. Studies on cell culture and animal models have demonstrated the potential of curcumin as an antioxidant, antibacterial, anti-inflammatory,
analgesic, wound healing, antiobesity, antiatherosclerosis, anticarcinogenic and neuroprotective agent. At molecular level, it showed the reversible epigenetic regulations include changes in DNA methylation, Histone modification and alteration in microRNA (miRNA) expression without changes in DNA sequence. This review discusses the chemical nature of curcumin and its regulation of epigenetic mechanisms leading to genome rearrangements and instability at theDNA level.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Modasiya MK and Patel VM. Studies on solubility of curcumin (IJPLS), 2012; 3:1490-1497.
Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The Essential Medicinal Chemistry of Curcumin. J Med Chem. 2017; 60:1620-1637.
Spice Board of India, New Delhi (India): Ministry of Commerce, Government of India. http://www.indianspices.com/pdf/ spicewisearprd.xls, 2011.
Kiuchi F, Goto Y, Sugimoto N, Akao N, Kondo K, Tsuda Y.Nematocidal activity of turmeric: synergistic action of curcuminoids. Chem Pharm Bull. 1993; 41(9):1640-1643.
Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK. Stability of curcumin in buffer solutions and characterization of its
degradation product. JPBA. 1997; 15(12):1867-1876.
Esatbeyoglu T, Huebbe P, Ernst IMA, Chin D, Wagner AE, Rimbach G. Curcumin: From Molecule to Biological Function. Angew chem. Int Ed. 2012; 51:2-27.
Weinhold Bob. Epigenetics: The Science of Change. EHP. 2006; 114(3):A160–A167.
Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004; 429:457-463.
Sarandeep S, Boyanapalli S, Kong A-N T. “Curcumin, the King of Spices”: Epigenetic Regulatory Mechanisms in the Prevention of Cancer, Neurological, and Inflammatory Diseases. Curr. Pharma Rep. 2015; 1(2):129-139.
Aggarwal BB, Prasad S, Reuter S, Kannappan R, Yadev VR, Park B, Kim JH, Gupta SC, Phromnoi K, Sundaram C, Chaturvedi MM, Sung B. Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: “reverse pharmacology” and “bedside to bench” approach. Curr. Drug Targets 2011; 12:1593-1653
Fu S. and Kurzrock R. Development of Curcumin as an Epigenetic Agent. Amer Cancer Soc. 2010; 116:4670-4676.
Teiten MH, Dicato M, Diederich M. Curcumin as a regulator of epigenetic events. Mol Nutr Food Res. 2013; 00:1-11.
Herman JG, and Baylin SB. Gene silencing in cancer in association with promoter hypermethylation, N. Engl J Med.2003; 349:2042-2054.
Reuter S, Gupta SC, Park B, Goel A, Aggarwal BB. Epigenetic changes induced by curcumin and other natural compounds, Gen Nutr. 2011; 6:93–108.
Liu Z, Xie Z, Jones W, Pavlovicz RE, Liu S, Yu J, Li PK, Lin J, Fuchs JR, Marcucci G, Li C, Chan KK. Curcumin is a potent DNA hypomethylation agent. Bioorg Med Chem Lett. 2009; 19:706-709.
Abusnina A, Keravis T, Yougbare I, Bronner C, Lungnier C. Antiproliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1. Mol Nutr Food Res. 2011; 55:1677-1689.
Du L, Xie Z, Wu LC, Chiu M, Lin J, Chan KK, Liu S, Liu Z.Reactivation of RASSF1A in breast cancer cells by curcumin. Nutr. Cancer 2012; 64:1228-1235.
Shu L, Khor TO, Lee JH, Boyanapalli SS, Huang Y, Wu TY, Saw CL, Cheung KL, Kong AN. Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. AAPS Pharm Sci Tech. 2011; 13:606-614.
Jha AK, Nikbakht M, Parashar G, Shrivastava A, Capalash N,Kaur J. Reversal of hypermethylation and reactivation of the RAR beta2 gene by natural compounds in cervical cancer cell lines. Folia Biol. 2010; 56:195-200.
Khor TO, Huang Y, Wu TY, Shu L, Lee J, Kong AN. Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation. Biochem Pharmacol. 2011; 82:1073-1078.
Parashar G, Parashar NC, Capalash N. Curcumin causes promoter hypomethylation and increased expression of FANCF gene in SiHa cell line. Mol Cell Biochem. 2012; 365:29-35.
Link A, Balaguer F, Shen Y, Lozano JJ, Leung H-CE, Boland CR, Goel A. Curcumin Modulates DNA Methylation in Colorectal Cancer Cells. PLoS ONE 2013; 8(2):e57709.
Wu B, Yao X, Nie X, Xu R. Epigenetic reactivation of RANK in glioblastoma cells by curcumin: involvement of STAT3 inhibition. DNA Cell Biol 2013; 32(6):292-297.
Lewinska A, Adamczyk J, Pajak J, Stoklosa S, Kubis B, Pastuszek P, Slota E, Wnuk M. Curcumin-mediated decrease in the expression of nucleolar organizer regions in cervical cancer (HeLa) cells. Mutat Res Genet Toxicol Environ Mutagen 2014; 771:43-5225.
Seffer I, Nemeth Z, Hoffmann G,Matics R, Seffer AG, Koller A. Unexplored Potentials of Epigenetic Mechanisms of Plants and Animals—Theoretical Considerations. Genet Epigenet 2013; 5:23-41.
Stefanska B, Karlic H, Varga F, Fabianowska-Majewska K,Haslberger AG. Epigenetic mechanisms in anti-cancer actions of bioactive food components-the implications in cancer prevention.Br J Pharmacol. 2012; 167:279-297.
Freitas MA, Sklenar AR, Parthun MR. Application of mass spectrometry to the identification and quantification of histone post-translational modifications. J Cell Biochem. 2004; 92(4): 691-700.
Rahman I, Marwick J, Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NFkappaB and pro-inflammatory gene expression. Biochem Pharmacol. 2004; 68:1255-1267.
Bora-Tatar G, Dayangac-Erden D, Demir AS, Dalkara S, Yelekci K, Erdem-Yurter H. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies. Bioorg Med Chem Lett. 2009; 17:5219-5228.
Liu HL, Chen Y, Cui GH, Zhou JF. Curcumin a potent anti-tumor reagent is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation. Acta Pharmacol. Sin. 2005; 26:603-609.
Chen Y, Shu W, Chen W, Wu Q, Liu H, Cui G. Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells. Basic Clin Pharmacol Toxicol. 2007; 101:427-433.
Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, Kindu TK. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem. 2004; 279:51163-51171.
Azad GK and Tomar RS. Epigenetics of Curcumin: A Gifted Dietary Therapeutics Compound. J Carcinog Mutagen 2015; 6:206.
Aggarwal R, Jha M, Shrivastava A, Jha AK. Natural compounds: role in reversal of epigenetic changes. Biochem. (Moscow).2015; 80(8):972-989.
Zhang J, Du Y, Wu C, Ren X, Ti X, Shi J, Zhao F, Yin H. Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186 signaling pathway. Oncol. Rep. 2010; 24:1217-1223.
Ali S, Ahmad A, Banerjee S, Padhye S, Dominiak K, SchaffertJM, Wang Z, Philip PA, Sarkar FH. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR200 and miR-21expression by curcumin or its analogue CDF. Cancer Res. 2010; 70:3606-3617.
Saini S, Arora S, Majid S, Shahryari V, Chen Y, Deng G, Yamamura S, Ueno K, Dahiya R. Curcumin modulate microRNA203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev Res. 2011; 4(10):1698-1709.
Howell JC, Chun E, Farrell AN, Hur EY, Caroti CM, Iuvone PM, Haque R. Global microRNA expression profiling: curcumin (diferuloylmethane) alters oxidative stress-responsive microRNAs in human ARPE-19 cells. Mol. Vis. 2013; 19:544-560.
Ali S, Ahmad A, Aboukameel A, Bao B, Padhye S, Philip PA, Sarkar FH. Increased Ras GTPase activity is regulated by miRNAs
that can be attenuated by CDF treatment in pancreatic cancer cells. Cancer Lett. 2012; 319:173-181